Clinical Trial Update: Sepantronium Bromide for the Treatment of High-grade B-cell Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update indicates Sepantronium bromide is being studied for high-grade B-cell lymphomas, with the study currently active but not recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma
• Burkitt Lymphoma
• Diffuse Large B-cell Lymphoma
• Double-hit Lymphoma
• High-grade B-cell Lymphoma

Drugs mentioned

• Sepantronium bromide (sepantronium bromide)

Snippet

Sponsor: Cothera Bioscience, Inc | Conditions: High-grade B-cell Lymphoma, Burkitt Lymphoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING